Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio
The biopharmaceutical company Jazz Pharmaceuticals (NASDAQ: JAZZ), has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc. (NASDAQ: GWPH).
Benzinga · 23h ago
New Strong Sell Stocks for May 6th
OYST, CDAY, GWPH, HRTG, and NATI have been added to the Zacks Rank #5 (Strong Sell) List on May 6, 2021
Zacks · 23h ago
CBD Oil Extract Market Share Projected To Reach $25.57 Billion by 2027
, /PRNewswire/ -- The CBD Oil extract market is growing but what exactly is making it grow? Recent reports indicate that it is the increasing preferences of oil and tinctures extracted from cannabis which is primarily driving the market growth rate. Out o...
PR Newswire - PRF · 1d ago
Jazz Pharma (JAZZ) Q1 Earnings Beat, Sales Miss, Stock Down
Jazz Pharmaceuticals (JAZZ) reports mixed first-quarter 2021 results as earnings beat estimates while sales miss the same. Shares down
Zacks · 1d ago
Jazz closes acquisition of GW Pharmaceuticals
Jazz Pharmaceuticals (JAZZ) has officially closed its $7.2B acquisition of GW Pharmaceuticals plc (GWPH).GW shareholders gave the thumbs up to the deal last month.With the acquisition, Jazz gains access to
Seekingalpha · 2d ago
Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc
DUBLIN, May 5, 2021 (PR Newswire Europe via COMTEX) -- DUBLIN, May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion...
PR Newswire Europe · 2d ago
Harvest Management Llc Buys GW Pharmaceuticals PLC, Inphi Corp, Alexion Pharmaceuticals Inc, ...
GuruFocus News · 2d ago
Study: U.K. Cannabis Industry Could Be Worth $2.8B Per Year If These Problems Are Fixed
A new research paper is shining light on the outdated laws and regulations currently hindering the U.K.’s CBD and medicinal cannabis industries. Written by Maple Tree Consultants and Mackrell. Solicitors, the paper is supported by sixteen industry heavywei...
Benzinga · 2d ago
Brown Trout Management, LLC Buys GW Pharmaceuticals PLC, TCF Financial Corp, Cardtronics PLC, ...
GuruFocus News · 2d ago
GW Pharma (GWPH) Gets a Hold Rating from Raymond James
In a report released yesterday, Danielle Brill from Raymond James maintained a Hold rating on GW Pharma (GWPH). The company's shares closed last Tuesday
SmarterAnalyst · 2d ago
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3)
Benzinga · 3d ago
Legal Cannabis Market Analysis 2021 : Market Size, Growth, Trends, Opportunities Forecast To 2026 with Top Countries Data
Japan, Japan, Mon, 03 May 2021 03:55:58 / Comserve Inc. / -- Competitive Analysis: Aurora Cannabis, Canopy Growth Corporation, Maricann Group, Inc., GW Pharmaceuticals, plc., Aphria, Inc., Tilray, The Cronos Group, ABcann Medicinals, Inc., Lexaria Corp., O...
Comserve · 4d ago
Cannabis Extract Market Size, Share, Trends, Analysis and Forecast 2027
The Global is estimated to value over USD 25.9 billion by 2027 end at a CAGR of over 16.6% during the forecast period 2020 to 2027.
Market Insight Reports · 4d ago
(EDGAR Online via COMTEX) -- Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations Note Regarding Forward-Looking...
Edgar Online - (EDG = 10Q, 10K) · 4d ago
Dowling & Yahnke Llc Buys Vanguard S&P 500 ETF, ARK Innovation ETF, iShares J.P. ...
GuruFocus News · 04/29 17:38
GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queens Award for Enterprise in Innovation
GW’s ground-breaking medicines development programme recognised for outstanding achievement in innovation with UK’s highest official award for British businessLONDON, April 29, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Comp...
GlobeNewswire · 04/29 00:09
Cannabis Beverages Market Segmentation Application, Technology and Market Analysis to 2027
Apr 28, 2021 (Market Insight Reports) -- The global cannabis beverage market was assessed at US$ 205 million in 2018, and is foreseen to reach US$ 2743.7...
Market Insight Reports · 04/28 13:15
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26)
Benzinga · 04/27 11:41
Is GW Pharmaceuticals (NASDAQ:GWPH) A Risky Investment?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Simply Wall St. · 04/26 12:03
GW Pharma shareholders approve $7.2B acquisition by Jazz
GW Pharmaceuticals (GWPH) shareholders have approved the $7.2B acquisition of the company by Jazz Pharmaceuticals (JAZZ).The High Court of Justice of England and Wales will hold a hearing on May 5
Seekingalpha · 04/23 20:20
Webull provides a variety of real-time GWPH stock news. You can receive the latest news about GW Pharma through multiple platforms. This information may help you make smarter investment decisions.
About GWPH
GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company is also focused on developing its pharmaceutical product pipelines, which includes Epidiolex for the treatment of Tuberous Sclerosis Complex and RETT Syndrome.